Copper Gluconate
Phase 1Small molecule
Copper Gluconate is one of 3 small molecule programs targeting Sarcomas. It is currently in Phase 1.
1
Indications
5
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
2 competitors in Sarcomas
#DrugCompanyPhaseTrials
1Antabuse
TevaPhase 1
Liposomal Doxorubicin
Eli LillyPhase 1
Copper Gluconate
UUniversity of Utah
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Refractory Solid Tumors1 trial
Multiple Myeloma1 trial
Glioblastoma1 trial
Prostate Cancer1 trial
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer
Terminated·—·Phase 1·NCT02963051·9 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Copper Gluconate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- UUniversity of Utah